Navigation Links
Biopharma Leaders to Reveal Successful Strategies for China, India at the PharmAsia Summit in San Francisco
Date:10/13/2010

f="http://www.ElsevierBI.com.">http://www.ElsevierBI.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com/) and Cell 9http://www.cell.com/), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (http://www.sciencedirect.com/), SciVerse Scopus (http://www.scopus.com/home.url), Reaxys ( http://notice.reaxys.com/maintenance.html), MD Consult ( http://www.mdconsult.com/php/222075573-2/homepage) and Nursing Consult (http://www.nursingconsult.com/php/222075595-2/home.html), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com/) and MEDai's Pinpoint Review (http://www.medai.com/), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com/wps/find/homepage.cws_home) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC ( http://www.reedelsevier.com/Pages/Home.aspx), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsev
'/>"/>

SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Helix BioPharma Completes Definitive GLP Toxicology Studies With L-DOS47 and is Making Final Preparations for its Planned Phase I/II Clinical Study IND/CTA Submissions
2. Genesis Biopharma to Present at the Informed Investors Forum Biotech, Healthcare & Pharma Virtual Conference on October 13
3. PDL BioPharma Completes October 1 Special Dividend Payment
4. Genesis Biopharma Announces $700K Private Financing
5. Signal Genetics Announces Partnership with Array BioPharma to Advance a Multiple Myeloma Program Backed by Companion Diagnostics
6. Keryx Biopharmaceuticals to Present at the UBS 2010 Global Life Sciences Conference
7. Helix BioPharma Approved for NYSE Amex Listing
8. PDL BioPharma Provides Clarification Regarding Redemption of Its 2.75% Convertible Subordinated Notes
9. PDL BioPharma Provides Third Quarter 2010 Revenue Guidance of Approximately $86 Million and Update to its Correspondence With Genentech
10. Reportlinker Adds Advances in Biopharmaceutical Technology in China
11. PDL BioPharma Announces Retirement of $61.6 Million of 2.75% Convertible Notes due August 2023 for Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Md., July 29, 2014  United Therapeutics Corporation ... its financial results for the second quarter ... growth shows that our medicines are reaching ... arterial hypertension (PAH)," said Martine Rothblatt, Ph.D., ... "The commercial launch this quarter of our ...
(Date:7/29/2014)... 2014 Dr. Jason Wendel – recipient of ... one of the Top 10 Plastic Surgeon Specialists for Nashville, ... products. His complete line includes a Hydration Booster, Retexturing Night ... face and skin a younger, more radiant appearance while protecting ... is different, that is why at Dr. J. J. Wendel ...
(Date:7/28/2014)... July 28, 2014 Sapphire Energy, Inc. ... announced the appointment of biotechnology veteran James Levine ... of directors. Levine replaces Cynthia ,CJ, Warner, who is ... remain chairman of the company,s board of directors. ... mission to deliver commercial scale algae-based fuels has been ...
(Date:7/28/2014)... 2014 Research and Markets has ... Market 2014-2018" report to their offering. ... synthetic biology covers the designing and engineering of completely ... the redesigning of natural biological systems that provide improved ... form of extreme genetic engineering because it not only ...
Breaking Biology Technology:United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 11United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 12United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 13Dr. J. J. Wendel Launches New Line of Skin Care Products 2Sapphire Energy Announces New CEO James Levine 2Sapphire Energy Announces New CEO James Levine 3Global Synthetic Biology Market 2014-2018 2
... 3 .decimal, Inc. announced today that,it has ... to supply,patient-specific devices for its proton therapy facility ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090203/CLTU104LOGO ) , ... a formal agreement signed with ProCure to be,their ...
... Sleep Apnea TreatmentSAN CARLOS, Calif., Feb. 3 ... shown their patients comply with Obstructive Sleep Apnea ... average.Analysis performed in October 2008 looked at Northern ... treatment with Positive Airway Pressure beginning in early ...
... Feb. 3 BioMarin Pharmaceutical Inc. (Nasdaq: ... Surveillance Agency, has granted BioMarin marketing approval for Naglazyme(R) ... (MPS VI)."We are very pleased to receive marketing approval ... number of affected MPS VI patients in the world," ...
Cached Biology Technology:ProCure Signs Agreement with .decimal, Inc. to Purchase Patient-Specific Devices for Its Proton Therapy Center in Oklahoma City 2SleepQuest Compliance Again Doubles Industry Average 2Naglazyme Approved by Brazil's National Health Surveillance Agency 2Naglazyme Approved by Brazil's National Health Surveillance Agency 3Naglazyme Approved by Brazil's National Health Surveillance Agency 4
(Date:7/28/2014)... South Pole in 1911, but new research shows that ... Using data from 16 ice cores collected from widely ... Pole, a group led by Joe McConnell of the ... most accurate and precise reconstruction to date of lead ... in an article published today in the online edition ...
(Date:7/28/2014)... Medicine have pinpointed a mechanism in part of the brain ... linking it to both type 1 and type 2 diabetes. ... Proceedings of the National Academies of Sciences . ... in a part of the hypothalamus known as the ventromedial ... control glucose levels in the blood," said lead author Sabrina ...
(Date:7/28/2014)... Ore. The findings of a new study suggest two ... may not work as well in obese women, compared to ... pills are a one-size-fits-all method, researchers say, but as the ... well the pill works for obese women. Studies have consistently ... in the body, which may in turn affect how well ...
Breaking Biology News(10 mins):Lead pollution beat explorers to South Pole, persists today 2Lead pollution beat explorers to South Pole, persists today 3Glucose 'control switch' in the brain key to both types of diabetes 2Strategies identified to improve oral contraceptive success with obese women 2
... cartilage injuries can be effectively repaired by tissue ... process concludes research led by scientists at the ... tissue engineered cartilage implanted in injured and osteoarthritic ... 12, Number 7) issue of Tissue Engineering, demonstrates ...
... that helps them recognize and isolate foreign DNA trying ... of Washington-led study in the June 8 issue of ... the Sidney Kimmel Cancer Center in San Diego, could ... bacteria. The findings may also impact the biotech industry, ...
... who are extremely obese may be underestimated as a new ... and high cholesterol than women at lower levels of obesity, ... JAMA. , Obesity diagnosis and treatment are typically based on ... calculated as weight in kilograms divided by height in meters ...
Cached Biology News:Bacteria have their own immune system protecting against outside DNA 2Higher levels of obesity associated with greater health risks 2Higher levels of obesity associated with greater health risks 3
Request Info...
Request Info...
XBP-1 (F-4)...
Mouse monoclonal [AE3] to Cytokeratin 1 - 8, prediluted ( Abpromise for all tested applications). Antigen: Tissue / cell preparation - Human epidermal cells. Entrez GeneID: 140807 Swiss P...
Biology Products: